JB Chemicals Appoints Aman Mehta As MD, Adds Four Directors To Board

JB Chemicals and Pharmaceuticals Limited has appointed Aman Mehta as Managing Director (MD), effective January 21, 2026. The appointment was approved on March 24, 2026.

The company also appointed Amal Kelshikar, Hasmukh Patel, Sudhir Menon, and Aman Mehta as Non-Executive Non-Independent Directors, effective March 23, 2026.

Mehta currently serves as MD at Torrent Pharmaceuticals and has experience in growth strategy, mergers and acquisitions (M&A), and market expansion. His role includes overseeing operations and participating in strategic decisions related to the group’s business activities. His work includes integrating acquisitions such as Unichem and expanding through new product launches and market-entry initiatives. He is also involved in evaluating acquisition opportunities and business planning. Mehta holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University.

Amal Kelshikar has experience in planning, marketing, sales, and licensing. Hasmukh Patel has worked in manufacturing, supply chain, and product development in the pharmaceutical sector. Sudhir Menon is Executive Director and Chief Financial Officer (CFO) at Torrent Pharmaceuticals and oversees finance, legal, IT, and investor relations.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: